Meet the MBA Class of ’27: Haley Lassiter

Haley Lassiter  

A bioengineer turned commercialization strategist, Haley bridges science and business to deliver measurable results. At Pathways Preclinical Partners, she develops branding, go-to-market, and investor strategies that accelerate biotech client acquisition and partnerships. Previously at Obatala Sciences, she co-led commercialization of ObaGel® ECM, built technical collateral, and drove a website/CRM rebuild that secured six-figure pharma contracts. A Harvard visiting fellow in bioengineering, she advanced obesity-on-a-chip models to support FDA regulatory requirements and therapeutic evaluation. With expertise spanning R&D, marketing, and strategy, Haley helps biopharma clients align complex science with growth, partnerships, and operational excellence.